ArticlePloS one2026
Characteristics of Escherichia coli ST131 strains isolated from dogs and cats with urinary tract infections in a teaching hospital in Taiwan.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Escherichia coli sequence type (ST) 131 is a globally disseminated multidrug-resistant clone that poses a substantial public health threat. This study investigated the prevalence, virulence characteristics, and antimicrobial resistance profiles of ST131 among companion-animal E. coli isolates. A total of 400 E. coli isolates obtained from dogs and cats diagnosed with urinary tract infections at the National Taiwan University Veterinary Hospital between 2011 and 2019 were analyzed. Phylogenetic grouping identified 192 isolates (48.0%) belonging to phylogroup B2, which is strongly associated with ST131. Among these, 26 isolates (13.5%) were confirmed as ST131 by single-nucleotide polymorphism screening and multilocus sequence typing, and 19 isolates were selected for detailed characterization. Virulence gene analysis by multiplex PCR showed that fyuA (100.0%), traT (94.7%), iutA (89.5%), and kpsMT II (84.2%) were the most prevalent genes. Antimicrobial susceptibility testing demonstrated universal susceptibility to meropenem, whereas all isolates were resistant to amoxicillin and ampicillin. Six canine-derived isolates produced extended-spectrum β-lactamases (ESBLs) or AmpC β-lactamases. Among ESBL producers, bla gene groups blaCTX-M-1, blaCTX-M-9, and blaTEM were detected, whereas blaCMY-178 was the only AmpC gene identified. Conjugation experiments demonstrated transferability for most bla genes, except blaTEM-102, blaTEM-12, and blaCTX-M-55. Plasmid replicon typing revealed IncF (100%) and IncB/O (69%) as the predominant plasmid groups. Only two O-antigen types, O25b and O16, were detected among ST131 isolates, which carried fimH variants fimH22, fimH27, fimH30, or fimH41 subclones. These findings demonstrate the circulation of virulent and multidrug-resistant ST131 strains in companion animals in Taiwan, highlighting their potential relevance within a One Health context.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.